(Q44220923)
Statements
1 reference
Phase I trial of ISIS 104838, a 2'-methoxyethyl modified antisense oligonucleotide targeting tumor necrosis factor-alpha (English)
1 reference
K Lea Sewell
1 reference
Richard S Geary
1 reference
Brenda F Baker
1 reference
Josephine M Glover
1 reference
Timothy G K Mant
1 reference
Rosie Z Yu
1 reference
Joseph A Tami
1 reference
F Andrew Dorr
1 reference
1 December 2002
1 reference
1 reference
Identifiers
1 reference